Estrogen Receptor Signalling: Bases for Drug Actions

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|5|3|305-314

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.5, Iss.3, 2005-09, pp. : 305-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

(-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions

By Jin G.-Z.   Zhu Z.-T.   Fu Y.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. : 4-7

Elsevier

Access to resources Recommend Favorite

G Proteins in Drug Screening: From Analysis of Receptor-G Protein Specificity to Manipulation of GPCR-Mediated Signalling Pathways

By  

Current Pharmaceutical Design, Vol. 12, Iss. 14, 2006-05 ,pp. : 1703-1715

Bentham Science Publishers

Access to resources Recommend Favorite

NPY Signalling Pathway in Bone Homeostasis: Y1 Receptor as a Potential Drug Target

By  

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 9-19

Bentham Science Publishers

Access to resources Recommend Favorite

Signalling without the receptor

By Wood I.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 10, 2000-10 ,pp. : 371-371

Elsevier

Access to resources Recommend Favorite

Mechanistic Insight of Drug Resistance with Special Focus on Iron in Estrogen Receptor Positive Breast Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 12, 2014-12 ,pp. : 1141-1157

Bentham Science Publishers

Access to resources Recommend Favorite